{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:29:54Z","timestamp":1790890194151,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejso.2026.111924","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:40:59Z","timestamp":1780501259000},"page":"111924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5715-9965","authenticated-orcid":false,"given":"Maximilian","family":"Filzmayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Quarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Petix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Carmignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Micali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kosiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Humke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix K.-H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111924_bib1","first-page":"93","article-title":"The Eighth Edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.111924_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.euf.2021.02.009","article-title":"Tumor stage and substage predict cancer-specific mortality after nephrectomy for nonmetastatic renal cancer: histological subtype-specific validation","volume":"8","author":"Nocera","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ejso.2026.111924_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2006.02.034","article-title":"Tumor size improves the accuracy of TNM predictions in patients with renal cancer","volume":"50","author":"Karakiewicz","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2026.111924_bib4","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/cncr.22629","article-title":"Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management","volume":"109","author":"Margulis","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2026.111924_bib5","first-page":"24","article-title":"Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large, Canadian, multi-institutional database","volume":"14","author":"Oake","year":"2020","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.ejso.2026.111924_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cncr.21125","article-title":"Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy","volume":"104","author":"Thompson","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2026.111924_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.juro.2007.03.104","article-title":"A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients","volume":"178","author":"Ficarra","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ejso.2026.111924_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.eururo.2010.07.006","article-title":"Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?","volume":"58","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2026.111924_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/mco.2023.2607","article-title":"Renal cell carcinoma T staging: diagnostic accuracy of preoperative contrast-enhanced computed tomography","volume":"18","author":"Fateh","year":"2023","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111924_bib10","first-page":"22","article-title":"Preoperative staging of renal cell carcinoma with multidetector CT","volume":"15","author":"T\u00fcrkvatan","year":"2009","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.ejso.2026.111924_bib11","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.clgc.2018.07.024","article-title":"Imaging in suspected renal-cell carcinoma: systematic review","volume":"17","author":"Vogel","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ejso.2026.111924_bib12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00345-011-0816-7","article-title":"Accuracy of multi-detector computed tomography (MDCT) in staging of renal cell carcinoma (RCC): analysis of risk factors for mis-staging and its impact on surgical intervention","volume":"31","author":"El-Hefnawy","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.ejso.2026.111924_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2214\/AJR.21.25493","article-title":"Update on the role of imaging in clinical staging and restaging of renal cell carcinoma based on the AJCC 8th edition, from the AJR special series on cancer staging","volume":"217","author":"Elkassem","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2026.111924_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2214\/ajr.182.1.1820217","article-title":"MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging","volume":"182","author":"Ergen","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2026.111924_bib15","unstructured":"Surveillance, epidemiology, and end results (SEER) program (www.seer.cancer.gov), National Cancer Institute, DCCPS, Surveillance Research Program, released April 2025, based on the November 2024 submission."},{"key":"10.1016\/j.ejso.2026.111924_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/1094428112470848","article-title":"Best-practice recommendations for defining, identifying, and handling outliers","volume":"16","author":"Aguinis","year":"2013","journal-title":"Organ Res Methods"},{"key":"10.1016\/j.ejso.2026.111924_bib17","article-title":"Giant renal cell Carcinoma (RCC): a case report of delayed diagnosis and management","volume":"15","author":"Villacreses","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejso.2026.111924_bib18","first-page":"2405","article-title":"Giant renal cell carcinoma with renal vein thrombus: a case report and surgical management","author":"Al Abdul Rahman","year":"2026","journal-title":"Int J Surgery Open"},{"key":"10.1016\/j.ejso.2026.111924_bib19","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/j.clgc.2020.01.005","article-title":"Has stage migration in renal cancer run its course? A SEER database analysis","volume":"18","author":"Haifler","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ejso.2026.111924_bib20","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.111924_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.euo.2018.08.023","article-title":"Clinical stage migration and survival for renal cell carcinoma in the United States","volume":"2","author":"Patel","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ejso.2026.111924_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2025.12.003","article-title":"Kidney-sparing treatments for local recurrence in renal cell tumours after partial nephrectomy or focal therapy: a systematic review","author":"Di Bello","year":"2025","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ejso.2026.111924_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41585-020-00382-9","article-title":"Sarcomatoid renal cell carcinoma: biology, natural history and management","volume":"17","author":"Blum","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ejso.2026.111924_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","article-title":"Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors","volume":"88","author":"Larcher","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2026.111924_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/01.pas.0000249446.28713.53","article-title":"Fuhrman grading is not appropriate for chromophobe renal cell carcinoma","volume":"31","author":"Delahunt","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2026.111924_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Fuhrman","year":"1982","journal-title":"Am J Surg Pathol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:45:37Z","timestamp":1784238337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326005433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0748798326005433"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111924","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111924"}}